Position in ALKS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$11,526
New position
Shares Held
220
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#355
of 421 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sachetta, LLC holds $71,971 across 7 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
36 | $19,505 | |
| 2 | VTRS |
Viatris Inc
|
1,190 | $18,896 | |
| 3 | ALKS |
Alkermes plc.
This page
|
220 | $11,526 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
59 | $9,943 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
283 | $6,964 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
145 | $5,027 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
1 | $110 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,526 | 220 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||